Sen. Tammy Baldwin features arguments in questions to SEC nominees, pharmaceutical industry witness
INET grantee William Lazonick has conducted extensive research on share buybacks, which was recently featured in letters sent by Sen. Tammy Baldwin (D-WI) to Securities and Exchange Commission nominees Robert J. Jackson, Jr. and Hester Pierce, and in written questions Senator Baldwin submitted to Lori M. Reilly, Executive Vice President for Policy, Research and Membership of the Pharmaceutical Research and Manufacturers of America (PhRMA), following a hearing on the price of pharmaceutical drugs.
Sen. Baldwin’s letters are at the right, and you may also find our Q&A with Lazonick on his research here. Lazonick’s research on the pharmaceutical industry and share buybacks has been featured in the New York Times.
